• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.82% Nasdaq Up 2.46%

    Alexza Pharmaceuticals Inc. (ALXA)

    -NasdaqCM
    1.16 Down 0.01(0.85%) Sep 2, 3:59PM EDT
    Add to Portfolio
    Prev Close:1.17
    Open:1.19
    Bid:N/A
    Ask:2.24 x 700
    1y Target Est:2.13
    Beta:-1.41686
    Earnings Date:Nov 3 - Nov 9 (Est.)
    Day's Range:1.13 - 1.20
    52wk Range:0.80 - 3.35
    Volume:7,079
    Avg Vol (3m):42,994
    Market Cap:22.56M
    P/E (ttm):N/A
    EPS (ttm):-1.73
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALXA

    Comparison

    Symbol% ChgMkt Cap
    ALXADown 0.85%22.56M
    ARDMUp 2.47%103.68M
    LLYUp 2.52%86.64B
    ALKSUp 6.23%9.43B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.07
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.19
    Quarterly EPS Est (Sep-15) :-0.34
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexza Pharmaceuticals, Inc., a pharmaceutical company, focuses on the research, development, and commercialization of proprietary products for the acute treatment of central nervous system conditions worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback